The global urology devices market is poised for sustained growth as healthcare providers increasingly adopt advanced diagnostic and minimally invasive treatment technologies for urinary tract and kidney disorders. Valued at US$ 38 Bn in 2021, the market is projected to grow at a CAGR of 5.6% from 2022 to 2031, reaching US$ 64 Bn by the end of 2031. Rising prevalence of chronic kidney disease (CKD), urinary incontinence, bladder cancer, prostate cancer, and end-stage renal disease (ESRD), coupled with technological innovations in robotic surgery and endoscopic equipment, is expected to drive market expansion throughout the forecast period.

Urology devices play a crucial role in diagnosing and treating diseases affecting the urinary bladder, kidneys, ureters, and urethra. From dialysis systems and catheters to robotic surgical platforms and laser lithotripsy equipment, modern urology technologies are improving treatment precision, reducing recovery time, and enhancing patient outcomes.

Growing Burden of Urological Disorders Driving Market Growth

The increasing incidence of urological diseases remains one of the strongest growth drivers for the global urology devices market. Lifestyle-related disorders such as diabetes, hypertension, obesity, and aging are significantly increasing the risk of kidney impairment and urinary tract diseases worldwide.

Urinary incontinence has become one of the most common yet underdiagnosed urological disorders, particularly among women and the elderly population. Millions of patients globally experience stress urinary incontinence and overactive bladder symptoms that require long-term medical management.

Studies indicate that approximately 200 million people worldwide suffer from urinary incontinence or bladder-related disorders. Women are affected nearly twice as often as men, and the prevalence continues to rise with age. The growing patient population is increasing demand for advanced diagnostic tools, catheters, drainage systems, and minimally invasive treatment devices.

Shift Toward Minimally Invasive Procedures

Healthcare providers and patients are increasingly preferring minimally invasive procedures over conventional open surgeries. These procedures offer several advantages, including smaller incisions, reduced pain, faster recovery, shorter hospital stays, and lower risk of infection.

Modern urology departments are investing heavily in advanced technologies such as robotic-assisted surgery, laser lithotripsy, flexible endoscopes, and laparoscopic systems. These innovations enable physicians to perform highly precise procedures for kidney stones, prostate disorders, bladder cancer, and urinary tract obstructions while improving clinical outcomes.

Technological advancements have also expanded the use of sophisticated diagnostic methods such as cystoscopy, urinalysis, and advanced imaging systems, allowing earlier detection and more effective treatment of urological diseases.

COVID-19 Increased Focus on Kidney Care

The COVID-19 pandemic highlighted the importance of kidney health and significantly influenced the demand for urology devices. Clinical studies demonstrated that many patients with severe COVID-19 developed acute kidney injury, even without pre-existing renal disease.

A substantial proportion of hospitalized COVID-19 patients required dialysis support due to kidney complications, increasing demand for dialysis equipment in hospitals and home-care settings. The pandemic also accelerated investments in advanced renal care technologies and strengthened healthcare infrastructure worldwide.

As healthcare systems continue expanding critical care capabilities, demand for dialysis products and kidney monitoring devices is expected to remain strong.

Manufacturers Prioritize Advanced Urology Equipment

Medical device manufacturers are continuously investing in research and development to introduce safer, more efficient, and technologically advanced urology equipment. Product innovation is focused on improving diagnostic accuracy, enhancing patient comfort, and simplifying minimally invasive surgical procedures.

The market is witnessing increasing adoption of robotic surgery platforms, next-generation urology lasers, advanced guidewires, ureteral stents, biopsy systems, and smart catheter technologies. These innovations are helping physicians perform complex procedures with greater precision while reducing complications and improving patient recovery.

Growing investments in healthcare infrastructure and favorable reimbursement policies are further encouraging hospitals and specialty clinics to upgrade their urology equipment.

Dialysis Products Continue to Dominate Product Segment

Based on product type, dialysis products represented the largest market segment, accounting for approximately 40% of the global market in 2021. The segment is expected to maintain its leadership while growing at a CAGR of 5.7% through 2031.

The increasing prevalence of chronic kidney disease and end-stage renal disease is significantly driving demand for dialysis machines, consumables, and related equipment. Diabetes remains one of the leading causes of kidney failure worldwide, contributing to the steady expansion of dialysis services.

In addition to dialysis products, demand continues to rise for:

• Endoscopes and endovision systems
• Laser and lithotripsy equipment
• Robotic surgical systems
• Urodynamic systems
• Urology catheters
• Biopsy devices
• Ureteral stents
• Guidewires
• Drainage bags

These devices play a critical role in both diagnosis and treatment across hospitals, ambulatory surgical centers, and dialysis clinics.

Hospitals Remain the Largest End-user

Hospitals accounted for the largest share of the global urology devices market and are expected to maintain their dominance during the forecast period. The increasing number of surgical procedures for kidney stones, prostate enlargement, urinary tract obstruction, bladder cancer, and other urological disorders is supporting market growth.

Hospitals continue investing in advanced endoscopy, laparoscopy, robotic surgery, and laser treatment systems to improve procedural efficiency and patient outcomes. Favorable reimbursement policies in developed countries further encourage adoption of advanced medical technologies.

Dialysis centers are also experiencing steady growth due to rising numbers of patients requiring long-term renal replacement therapy.

North America Leads Global Market

North America accounted for more than 37% of the global urology devices market in 2021, supported by advanced healthcare infrastructure, early adoption of innovative medical technologies, and a large patient population affected by kidney and urinary disorders.

High healthcare expenditure, strong reimbursement policies, and the presence of leading medical device manufacturers continue to strengthen the regional market. The growing prevalence of diabetes and hypertension—major contributors to chronic kidney disease—is further increasing demand for dialysis systems and minimally invasive urology devices.

Europe remains the second-largest regional market, with increasing incidence of kidney stones and favorable healthcare policies supporting growth. Meanwhile, Asia Pacific is projected to register the fastest expansion during the forecast period due to its large population, rapidly improving healthcare infrastructure, expanding geriatric population, and growing investments in medical technology across countries such as China, India, and Japan.

Competitive Landscape

The global urology devices market is highly competitive and fragmented, with numerous multinational and regional manufacturers competing through technological innovation, strategic partnerships, mergers, and acquisitions.

Leading companies operating in the market include:

• Olympus Corporation
• Boston Scientific Corporation
• KARL STORZ SE & Co. KG
• Becton, Dickinson and Company (C. R. Bard)
• Richard Wolf GmbH
• Intuitive Surgical
• Fresenius Medical Care
• Coloplast
• Medtronic
• Siemens Healthineers
• Stryker
• Cardinal Health
• Baxter
• HealthTronics, Inc.
• Johnson & Johnson
• Cook Medical

Recent industry developments continue to shape market competition. In 2022, Johnson & Johnson's Auris Health received FDA clearance for its Monarch robotic surgery platform for kidney stone removal, expanding robotic applications in urology. In 2021, UroCure partnered with LiNA Medical USA to strengthen distribution of minimally invasive treatments for female urinary incontinence, reflecting the industry's growing focus on innovative women's health solutions.

Future Outlook

The global urology devices market is expected to witness stable growth through 2031 as healthcare systems continue prioritizing early diagnosis, minimally invasive treatment, and improved management of kidney and urinary tract disorders. Rising disease prevalence, technological advancements in robotic surgery and endoscopy, increasing demand for dialysis products, and expanding healthcare access in emerging economies will continue to drive market expansion.

As manufacturers invest in next-generation medical devices that enhance procedural precision, patient safety, and clinical outcomes, the urology devices market is set to remain a vital segment of the global medical technology industry over the coming decade.